United States· US:69729-791_4dc7f12f-7e83-aca2-e063-6294a90ac1dc
RIOPAN
A esomeprazole product containing esomeprazole magnesium, registered in United States by OPMX LLC. The same ATC class is registered in 19 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Esomeprazole is registered in 19 of 19 countries.
Countries holding a registration under ATC A02BC05 (esomeprazole), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Esomeprazole · ATC A02BC05
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of esomeprazole costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.12 in France to $0.69 in Switzerland — a ×5.7 gap.
- United States: $0.25 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Esomeprazole · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.69
- ES Spain$0.51
- IT Italy$0.34
- US United States$0.25 (acquisition cost)
- FI Finland$0.21
- FR France$0.12
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ESOMEPRAZOLE MAGNESIUM
- Manufacturer
- OPMX LLC
- Country
- United States (US)
- ATC code
- A02BC05
- ATC class
- Esomeprazole
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1169729-791-14
- ndc1169729791141 BOTTLE in 1 CARTON (69729-791-14) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
201 interactions on record for esomeprazole.
Graded by severity as the source publishes them — 24 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Esomeprazole · interactions on record
201 records
- 24 severe
- 122 moderate
- 45 minor
Most severe, free to view
- ClopidogrelB01AC04severe
- NelfinavirJ05AE04severe
- AtazanavirJ05AE08severe
- RilpivirineJ05AG05severe
10 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Esomeprazole in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyARILIARS.F. GROUP S.R.L.
- FranceESOMEPRAZOLE ALMUS 20 mg, gélule gastro-résistanteALMUS FRANCE
- United KingdomEmozul 20mg gastro-resistant capsulesKrka UK Ltd
- SpainEMANERA 20 MG CÁPSULAS DURAS GASTRORRESISTENTES EFGKrka D.D. Novo Mesto
- NetherlandsEsomeprazol 20 mg PCH, maagsapresistente capsules, hardPharmachemie B.V.
- SwedenEsomeprazol Krka 20 mg Enterokapsel, hårdKrka d.d., Novo mesto
- PolandEmaneraKrka, d.d., Novo mesto
- IrelandESCADRA 20 mg hard gastro-resistant capsulesKRKA, d.d., Novo mesto
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Durotiv, Esomeprazol +pharma
- Belgium · Esomeprazol Ab, Esomeprazole Ab
- Bulgaria · Esomeprazole Tchaikapharma, Refstop
- Cyprus · Demolox, Esomeprazole Krka
- Czechia · Emanera, Esomeprazole Olikla
- Germany · Esogasec, Esomeaxiro
- Denmark · Abigerd, Dansiglat
- Estonia · Elfimest, Escadra
- Spain · Axiago, Emanera
- Finland · Acidal, Esomeprazol Actavis
- France · Celardes, Esodomin
- United Kingdom (Northern Ireland) · Asda Heartburn And Acid Reflux Control, Boots Heartburn And Acid Reflux Control
- Greece · Demolox, Epivetier
- Croatia · Cidiref, Emanera
- Hungary · Emanera, Emozul
- Ireland · Emazole, Emazole Control
- Iceland · Esomeprazol Actavis, Esomeprazol Hexal
- Italy · Abigerd, Ariliar
- Liechtenstein · Nexium Control
- Lithuania · Elfimest, Escadra
- Luxembourg · Esomeprazol Ab, Esomeprazol Ratiopharm
- Latvia · Elfimest, Escadra
- Malta · Emazole, Emazole Control
- Netherlands · Esobax, Esomeprazol Accord
- Norway · Esogrc, Esomeprazol Actavis
- Poland · Alugastrin, Emanera
- Portugal · Demoel, Esomeprazol Accord
- Romania · Emanera, Esomeprazol Rompharm
- Sweden · Axiago, Cativa
- Slovenia · Emozul, Eslaver
- Slovakia · Dereflin, Emanera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af2cfaea-a03c-4d44-aff2-4393713f4458 GET /v1/drugs/af2cfaea-a03c-4d44-aff2-4393713f4458?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "20",
"substance": "ESOMEPRAZOLE MAGNESIUM",
"productndc": "69729-791",
"dosage_form": "CAPSULE, DELAYED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA212507",
"marketing_category": "ANDA"
}See everything about esomeprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.